Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma

NCT01312961 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Dupilumab
DRUG: Placebo (for Dupilumab)
DRUG: Fluticasone/Salmeterol combination therapy
DRUG: Fluticasone monotherapy
DRUG: Albuterol
DRUG: Levalbuterol

Sponsor

Sanofi

Collaborators

[object Object]